Camrelizumab combined with rivoceranib and TACE in the perioperative treatment of hepatocellular carcinoma: A randomized, open-label multicenter trial. This is an ASCO Meeting Abstract from the 2025 ...
The semiconductor industry, as always, is at the forefront of transformational technological innovation, driving escalating complexity of manufacturing processes that extend time-to-market delivery, ...
CAR T-cell therapy has revolutionized cancer treatment for B cell and plasma cell malignancies, turning patients’ own immune cells into cancer-fighting superheroes—but even superheroes can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results